LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 67.10 | 771.67 | 7400 | 9800 | 0.7551 | 0.8525 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.32 | 771.67 | 5955 | 10212 | 0.5831 | 0.7305 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 69.32 | 771.67 | 7555 | 10212 | 0.7398 | 0.8446 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.54 | 771.67 | 5982 | 10532 | 0.5679 | 0.7214 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 71.54 | 771.67 | 7783 | 10532 | 0.7389 | 0.8458 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.76 | 771.67 | 6092 | 10851 | 0.5614 | 0.7190 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 73.76 | 771.67 | 7940 | 10851 | 0.7317 | 0.8427 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.02 | 771.67 | 6115 | 11106 | 0.5506 | 0.7126 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 76.02 | 771.67 | 8140 | 11106 | 0.7329 | 0.8448 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.25 | 771.67 | 5962 | 11367 | 0.5245 | 0.6936 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 78.25 | 771.67 | 8318 | 11367 | 0.7317 | 0.8453 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.48 | 771.67 | 6237 | 11685 | 0.5338 | 0.7041 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 80.48 | 771.67 | 8391 | 11685 | 0.7181 | 0.8380 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.69 | 771.67 | 6416 | 11974 | 0.5358 | 0.7082 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 82.69 | 771.67 | 8481 | 11974 | 0.7083 | 0.8330 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 84.92 | 771.67 | 6372 | 12266 | 0.5195 | 0.6973 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 84.92 | 771.67 | 8652 | 12266 | 0.7053 | 0.8325 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 87.14 | 771.67 | 5778 | 12592 | 0.4588 | 0.6483 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 87.14 | 771.67 | 8730 | 12592 | 0.6933 | 0.8262 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 2.49 | 771.67 | 843 | 867 | 0.9715 | 0.6858 | MN20160304_L01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 2.49 | 771.67 | 836 | 867 | 0.9634 | 0.6048 | MN20160304_L01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 2.49 | 771.67 | 864 | 867 | 0.9957 | 0.9495 | MN20160304_L01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 4.71 | 771.67 | 930 | 956 | 0.9724 | 0.8273 | MN20160304_L01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 4.71 | 771.67 | 965 | 956 | 1.0090 | 1.0588 | MN20160304_L01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 4.71 | 771.67 | 1008 | 956 | 1.0540 | 1.3702 | MN20160304_L01 | I21 |